Diabetes Medications
Taking anti-glycemic medications is a key evidence-based intervention for people with diabetes to achieve their blood glucose targets. The challenge for diabetes professionals is to keep updated on what they NEED TO KNOW about all the many oral and injectable diabetes drugs currently on the market (including insulins) in order to furnish quality diabetes care and education to their patients. This presentation formats the oral drugs into those with a high and a low risk for hypoglycemia. Within each of these 2 categories are the drugs best suited for controlling fasting blood glucose and post-meal glucose, with supporting details on each drug's brand and generic names, risks, benefits, sites and mechanisms of actions, reported advantages and disadvantages, and application route. Basal and bolus insulin therapy in T1 and T2 diabetes are reviewed, including insulin types, how to calculate starting doses, how to prepare and inject insulin doses, and syringe, needle and pen types. Challenging insulin FAQs are reviewed, along with the newest "Medication Algorithm for the Management of Type 2 Diabetes."

This is one presentation you do not want to miss. Special bonus: the slides deck will be a great desk top diabetes medication reference for you and your staff.
Upon successful completion of this two-hour course, the participant should be able to name:
  • the sites of action (target organs) of the current diabetes medications.

  • 5 of the many considerations for prescribing medications for diabetes.

  • the 4 lifestyle interventions recommended for PWDs, and the first medication to be prescribed as 'monotherapy', per the ADA.

  • the 6 'dual' medication therapies if the A1c target is not achieved after 3 months of monotherapy, per the ADA.

  • the diabetes medications with a low risk of hypoglycemia used primarily to control fasting and pre-meal blood glucose.

  • the diabetes medications with a low risk of hypoglycemia used primarily to control post-meal blood glucose.

FOR CDEs: This Course Qualifies for CE Credit!

To satisfy the requirement for renewal of certification according to the National Certification Board for Diabetes Educators (NCBDE, www.ncbde.org), courses must relate to diabetes and be part of the list of recognized providers of the NCBDE. The Commission on Dietetic Registration (CDR) is listed as an NCBDE recognized provider. Because Dietitian Central has been granted accreditation by the CDR, it therefore meets the criteria as an approved provider of CEs for CDEs by the NCBDE. The NCBDE does not directly approve continuing education for any specific webinar or self study course.
Live Webinar Date: Mar 21, 2017   (02:00 PM - 04:00 PM EST)
Course Categories / Learning Need Codes (LNC): 4040, 5190, 5460, 7130
Performance Indicators/Learning Objectives: 10.4.1, 10.4.2, 10.4.3
Target Audience: RDs, CDEs, Health Professionals
Number of Credits: 2.0
Level(s): 1, 2
Total Cost: $36

About the Presenter: Mary Ann Hodorowicz, RD, CDE, MBA, Certified Endocrinology Coder

Mary Ann Hodorowicz, RD, CDE, MBA, Certified Endocrinology Coder owns a practice in Palos Heights, IL, (Mary Ann Hodorowicz Consulting, LLC) that specializes in customized consulting, training, writing and professional presentation services for the healthcare and food industry in these areas:

  • Medical Nutrition Therapy (MNT)
  • Diabetes Self-Management Education (DSME)
  • Diabetes Care Services: Shared Medical Appointments, CGM, CSII, SMBG, Etc.
  • Business Management Components (Clinical, Marketing, Operational, Financial, Quality Management)
  • Medicare and Private Payer Insurance Reimbursement for the above
  • Evidence-Based Standards of Diabetes Care
  • Achieving AADE Accreditation for DSME Programs (turn-key materials and Policy and Procedure Manual)
  • Motivational Interviewing/Patient Empowerment Counseling for HCPs
  • Nutrition Education and Health/Wellness Promotion Programs for Consumers
Her clients include healthcare entities, professional membership associations, pharmacies, medical CEU education and training firms, government agencies, food and pharmaceutical companies, academia, and employer groups. She served on the Board of Directors of the American Association of Diabetes Educators from 2013 – 2015, and was the Chair of AADE’s Advanced Practice Community of Interest in 2016.


Diabetes Medication Update

On-Demand Webinar

RDs and the Patient with Osteoporosis

On-Demand Webinar